Jason Drew Smith

URGN

Jason Drew Smith serves as General Counsel at UroGen Pharma Ltd. (URGN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$39.3K

Total Sells

1 trades

$144.0K

Net Position

Net Seller

$104.7K

Companies Traded

URGN

Active Period

May 2021 – Jul 2025

2 total trades

Most Recent

Sell URGN

Jul 28, 2025 · $144.0K

Jason Drew Smith's Insider Trading at UroGen Pharma Ltd. (URGN)

Buys

1 · $39.3K

Sells

1 · $144.0K

Total Shares Bought

2,500

Total Shares Sold

7,522

URGN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 28, 2025	Sell	7,522	$19.14	$144.0K	0
May 18, 2021	Buy	2,500	$15.71	$39.3K	2,500

Related Insiders

Mark Schoenberg

Chief Medical Officer

URGNSell · Sep 7, 2025

Explore More Insider Trading Data

URGN Insider Trading Activity

View all insider trades at UroGen Pharma Ltd.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity